Skip to main content

News

By Beth Jones Sanborn | 11:37 am | October 04, 2016
Organizations will focus on assessing the feasibility of the new measures within Medicaid and CHIP patient populations.
By Beth Jones Sanborn | 11:01 am | October 04, 2016
Struggling healthcare company says provision will thwart any acquisition of a controlling block of stock for six months.
By Susan Morse | 03:54 pm | October 03, 2016
Staffing and productivity issues remain, and with grace periods over, that could spell trouble.
By Beth Jones Sanborn | 03:28 pm | October 03, 2016
Payout settles allegations of illegal kickbacks paid to clinic owners in exchange for referring patients for labor and delivery services to Tenet facilities.
By Jeff Lagasse | 03:07 pm | October 03, 2016
Just two teaching hospitals with at least 500 beds earned top C. diff prevention scores, meaning their infection rates were 50 percent better than the national benchmark.
By Jeff Lagasse | 01:47 pm | October 03, 2016
Benchmarks for expected returns are also needed, it said, as well as a deeper understanding of how investment mechanisms, such as bonds and social finance, can help improve healthcare.
By Kaiser Health News | 12:05 pm | October 03, 2016
This summer, the federal government directed $1.4 million to five pilot projects located in southwest Virginia as well as Tennessee and Kentucky.
By Beth Jones Sanborn | 10:03 am | October 03, 2016
Ohsumi performed pioneering experiments during the 90's that broadened the understanding of a process called autophagy.
By Kaiser Health News | 09:55 am | October 03, 2016
Since the medicine generally expires every year, the cost to replace EpiPens adds up fairly quickly, especially for consumers who do not have insurance or have high-deductible plans.
By Kaiser Health News | 09:34 am | October 03, 2016
Naltrexone and acamprosate are the two drugs on the market for patients with alcohol cravings.